s6y

S-4 Registration of securities issued in business combination transactions

Filed
Accession number
0001213900-21-017053

Documents

  1. fs42021_alphahealthcareacq.htm S-4
  2. OPINION OF GOODWIN PROCTER LLP EX-5.1
  3. FORM OF SUBSCRIPTION AGREEMENT EX-10.3
  4. DISTRIBUTION AGREEMENT, DATED JUNE 25, 2018, BY AND BETWEEN FRESENIUS MEDICAL CARE HOLDINGS, INC. AND HUMACYTE, INC EX-10.6
  5. FIRST AMENDMENT TO DISTRIBUTION AGREEMENT, DATED OCTOBER 2, 2019, BY AND BETWEEN FRESENIUS MEDICAL CARE HOLDINGS, INC. AND HUMACYTE, INC EX-10.6I
  6. SECOND AMENDMENT TO DISTRIBUTION AGREEMENT, EFFECTIVE AS OF FEBRUARY 16, 2021, BY AND BETWEEN FRESENIUS MEDICAL CARE HOLDINGS, INC. AND HUMACYTE, INC EX-10.6II
  7. EXCLUSIVE LICENSE AGREEMENT, DATED FEBRUARY 25, 2014, BY AND BETWEEN YALE UNIVERSITY AND HUMACYTE, INC EX-10.7
  8. EXCLUSIVE LICENSE AGREEMENT, DATED AUGUST 13, 2019, BY AND BETWEEN YALE UNIVERSITY AND HUMACYTE, INC EX-10.8
  9. EXCLUSIVE LICENSE AGREEMENT, DATED AUGUST 25, 2019, BY AND BETWEEN YALE UNIVERSITY AND HUMACYTE, INC EX-10.9
  10. EXCLUSIVE PATENT LICENSE AGREEMENT, DATED MARCH 14, 2006, BETWEEN DUKE UNIVERSITY AND HUMACYTE, INC EX-10.10
  11. FIRST AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT, DATED FEBRUARY 25, 2011, BETWEEN DUKE UNIVERSITY AND HUMACYTE, INC. EX-10.10I
  12. SECOND AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT, DATED APRIL 24, 2014, BETWEEN DUKE UNIVERSITY AND HUMACYTE, INC EX-10.10II
  13. THIRD AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT, DATED JUNE 26, 2015, BETWEEN DUKE UNIVERSITY AND HUMACYTE, INC EX-10.10III
  14. FOURTH AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT, DATED JANUARY 2, 2018, BETWEEN DUKE UNIVERSITY AND HUMACYTE, INC EX-10.IV
  15. FIFTH AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT, DATED DECEMBER 31, 2019, BETWEEN DUKE UNIVERSITY AND HUMACYTE, INC EX-10.10V
  16. SUPPLY AGREEMENT, DATED JANUARY 9, 2014, BETWEEN SERACARE LIFE SCIENCES, INC. AND HUMACYTE, INC EX-10.11
  17. FIRST AMENDMENT TO SUPPLY AGREEMENT, DATED OCTOBER 12, 2018, BETWEEN SERACARE LIFE SCIENCES, INC. AND HUMACYTE, INC EX-10.11I
  18. SUPPLY AGREEMENT, DATED AUGUST 31, 2015, BETWEEN CONFLUENT MEDICAL TECHNOLOGIES (FORMERLY KNOWN AS BIOMEDICAL STRUCTURES LLC) AND HUMACYTE, INC EX-10.12
  19. EXECUTIVE EMPLOYMENT AGREEMENT, DATED FEBRUARY 3, 2021, BETWEEN LAURA NIKLASON, M.D., PH.D. AND HUMACYTE, INC EX-10.13
  20. EXECUTIVE EMPLOYMENT AGREEMENT, DATED JUNE 19, 2018, BETWEEN JEFFREY LAWSON, M.D. AND HUMACYTE, INC EX-10.14
  21. AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT, DATED FEBRUARY 3, 2021, BETWEEN JEFFREY LAWSON, M.D. AND HUMACYTE, INC EX-10.14I
  22. EXECUTIVE EMPLOYMENT AGREEMENT, DATED OCTOBER 8, 2018, BETWEEN DOUGLAS BLANKENSHIP AND HUMACYTE, INC EX-10.15
  23. EXECUTIVE EMPLOYMENT AGREEMENT, DATED SEPTEMBER 13, 2019, BETWEEN HEATHER PRICHARD, PH.D. AND HUMACYTE, INC EX-10.16
  24. HUMACYTE, INC. 2005 STOCK OPTION PLAN EX-10.18
  25. FIRST AMENDMENT OF HUMACYTE, INC. 2005 STOCK OPTION PLAN, DATED MARCH 31, 2008 EX-10.18I
  26. SECOND AMENDMENT OF HUMACYTE, INC. 2005 STOCK OPTION PLAN, DATED OCTOBER 28, 2011 EX-10.18II
  27. THIRD AMENDMENT OF HUMACYTE, INC. 2005 STOCK OPTION PLAN, DATED NOVEMBER 22, 2013 EX-10.18III
  28. FORM OF INCENTIVE STOCK OPTION AGREEMENT UNDER HUMACYTE, INC. 2005 STOCK OPTION PLAN EX-10.18IV
  29. FORM OF NONSTATUTORY STOCK OPTION AGREEMENT UNDER HUMACYTE, INC. 2005 STOCK OPTION PLAN EX-10.18V
  30. HUMACYTE, INC. 2015 OMNIBUS INCENTIVE PLAN EX-10.19
  31. FIRST AMENDMENT TO HUMACYTE, INC. 2015 OMNIBUS INCENTIVE PLAN, DATED FEBRUARY 23, 2018 EX-10.19I
  32. SECOND AMENDMENT TO HUMACYTE, INC. 2015 OMNIBUS INCENTIVE PLAN, DATED JUNE 6, 2018 EX-10.19II
  33. FORM OF INCENTIVE STOCK OPTION AGREEMENT UNDER HUMACYTE, INC. 2015 OMNIBUS INCENTIVE PLAN EX-10.19III
  34. FORM OF NONSTATUTORY STOCK OPTION AGREEMENT UNDER HUMACYTE, INC. 2015 OMNIBUS INCENTIVE PLAN EX-10.19IV
  35. ANNUAL BONUS PLAN EX-10.20
  36. LEASE AGREEMENT, DATED DECEMBER 31, 2015, BETWEEN ARE-NC REGION NO. 5, LLC AND HUMACYTE, INC EX-10.22
  37. FIRST AMENDMENT TO LEASE, DATED SEPTEMBER 30, 2016, BETWEEN ARE-NC REGION NO. 5, LLC AND HUMACYTE, INC EX-10.22I
  38. SECOND AMENDMENT TO LEASE, DATED FEBRUARY 8, 2017, BETWEEN ARE-NC REGION NO. 5, LLC AND HUMACYTE, INC EX-10.22II
  39. THIRD AMENDMENT TO LEASE, DATED APRIL 21, 2017, BETWEEN ARE-NC REGION NO. 5, LLC AND HUMACYTE, INC EX-10.22III
  40. FOURTH AMENDMENT TO LEASE, DATED OCTOBER 31, 2017, BETWEEN ARE-NC REGION NO. 5, LLC AND HUMACYTE, INC EX-10.22IV
  41. SUBSIDIARIES OF ALPHA HEALTHCARE ACQUISITION CORP EX-21.1
  42. CONSENT OF MARCUM LLP EX-23.2
  43. CONSENT OF PRICEWATERHOUSECOOPERS LLP EX-23.3
  44. CONSENT OF LAURA E. NIKLASON, M.D., PH.D EX-99.3
  45. CONSENT OF BRADY W. DOUGAN EX-99.4
  46. CONSENT OF EMERY N. BROWN, M.D., PH.D EX-99.5
  47. CONSENT OF KATHLEEN SEBELIUS EX-99.6
  48. CONSENT OF MAX WALLACE, J.D EX-99.7
  49. CONSENT OF SUSAN WINDHAM-BANNISTER, PH.D EX-99.8

On sec.gov